Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Artesunate 💬1件: Artesunate1件: Artesunate--4件: 18, 66, 86, 96 💬
2 Baclofen 💬1件: Baclofen1件: Baclofen2件: GABBR1,
GABBR2 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬8件: 2, 10, 13, 18, 65, 70, 149, 206 💬
3 Bupropion 💬1件: Bupropion2件: Bupropion; Bupropion Hydrochloride2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬7件: 8, 18, 21, 96, 97, 171, 298 💬
4 Bupropion hydrobromide 💬1件: Bupropion2件: Bupropion; Bupropion Hydrochloride2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬7件: 8, 18, 21, 96, 97, 171, 298 💬
5 Bupropion hydrochloride 💬1件: Bupropion2件: Bupropion; Bupropion Hydrochloride2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬7件: 8, 18, 21, 96, 97, 171, 298 💬
6 Calcitriol 💬1件: Calcitriol1件: Calcitriol1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬11件: 18, 37, 46, 49, 66, 96, 158, 223, 235, 238, 326 💬
7 Citalopram 💬1件: Citalopram1件: Citalopram1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬7件: 6, 8, 13, 18, 46, 98, 127 💬
8 Citalopram hydrobromide 💬1件: Citalopram1件: Citalopram1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬7件: 6, 8, 13, 18, 46, 98, 127 💬
9 Deferiprone 💬1件: Deferiprone1件: DEFERIPRONE--7件: 2, 6, 18, 121, 122, 139, 233 💬
10 Elamipretide 💬1件: Elamipretide1件: Elamipretide--3件: 18, 21, 324 💬
11 Elamipretide hydrochloride 💬1件: Elamipretide1件: Elamipretide--3件: 18, 21, 324 💬
12 Epoetin alfa 💬1件: Erythropoietin3件: Epoetin alfa; Erythropoietin; RhEPO1件: EPOR 💬 7件: Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬11件: 2, 6, 13, 18, 22, 47, 61, 63, 70, 95, 96 💬
13 Epoetin epsilon 💬1件: Erythropoietin3件: Epoetin alfa; Erythropoietin; RhEPO1件: EPOR 💬 7件: Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬11件: 2, 6, 13, 18, 22, 47, 61, 63, 70, 95, 96 💬
14 Epoetin theta 💬1件: Erythropoietin3件: EPOETIN ALFA; Erythropoietin; RhEPO1件: EPOR 💬 7件: Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬11件: 2, 6, 13, 18, 22, 47, 61, 63, 70, 95, 96 💬
15 Epoetin zeta 💬1件: Erythropoietin3件: EPOETIN ALFA; Erythropoietin; RhEPO1件: EPOR 💬 7件: Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬11件: 2, 6, 13, 18, 22, 47, 61, 63, 70, 95, 96 💬
16 Etravirine 💬1件: Etravirine2件: ETRAVIRINA; Etravirine--1件: 18 💬
17 Ferrous fumarate 💬1件: Iron1件: Iron--7件: 18, 60, 96, 97, 238, 254, 284 💬
18 Flumazenil 💬1件: Flumazenil1件: Flumazenil16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		9件: Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬5件: 6, 13, 17, 18, 206 💬
19 Fursultiamine 💬1件: Fursultiamine1件: Fursultiamine--2件: 6, 18 💬
20 Fursultiamine hydrochloride 💬1件: Fursultiamine1件: Fursultiamine--2件: 6, 18 💬
21 Gabapentin 💬1件: Gabapentin3件: Gabapentin; GABAPENTINA; Gabapentine5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬7件: 6, 13, 18, 19, 70, 226, 298 💬
22 Ginkgo 💬1件: Ginkgo biloba1件: Ginkgo biloba--4件: 13, 18, 47, 90 💬
23 Idebenone 💬1件: Idebenone1件: IDEBENONE--9件: 6, 8, 13, 17, 18, 21, 113, 115, 302 💬
24 Interferon gamma-1b 💬1件: Interferon gamma-1b1件: Interferon gamma-1b2件: IFNGR1,
IFNGR2 💬 		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬7件: 18, 65, 85, 228, 299, 301, 326 💬
25 Lenograstim 💬1件: Lenograstim2件: G-CSF; LENOGRASTIM1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬8件: 2, 13, 16, 18, 19, 57, 65, 97 💬
26 Leucine 💬1件: Leucine2件: L-leucine; Leucine--13件: 5, 6, 7, 18, 19, 65, 96, 97, 127, 280, 283, 284, 299 💬
27 Lithium carbonate 💬1件: Lithium carbonate1件: LITHIUM CARBONATE--6件: 2, 13, 17, 18, 127, 310 💬
28 Methylprednisolone 💬1件: Methylprednisolone3件: Methylprednisolon; METHYLPREDNISOLONE; METHYLPREDNISOLONE ACETATE1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬51件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
29 Methylprednisolone acetate 💬1件: Methylprednisolone3件: Methylprednisolon; METHYLPREDNISOLONE; METHYLPREDNISOLONE ACETATE1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬51件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
30 Niacinamide 💬1件: Nicotinamide2件: Niacinamide; Nicotinamide--19件: 2, 5, 6, 7, 8, 17, 18, 21, 46, 49, 60, 63, 65, 85, 97, 107, 162, 191, 302 💬
31 Omaveloxolone 💬1件: Omaveloxolone1件: Omaveloxolone1件: NFE2L2 💬 7件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬1件: 18 💬
32 Prednisolone 💬1件: Prednisolone3件: Prednisolona; PREDNISOLONE; Prednisolonum1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬48件: 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
33 Prednisone 💬1件: Prednisone2件: PREDNISONA; Prednisone1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬58件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
34 Riluzole 💬1件: Riluzole1件: Riluzole14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬9件: 2, 3, 5, 8, 13, 17, 18, 203, 206 💬
35 Rosuvastatin 💬1件: Rosuvastatin2件: Rosuvastatin; ROSUVASTATIN CALCIUM1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬16件: 6, 18, 46, 49, 51, 56, 57, 62, 65, 67, 79, 94, 96, 97, 271, 299 💬
36 Rosuvastatin calcium 💬1件: Rosuvastatin2件: Rosuvastatin; ROSUVASTATIN CALCIUM1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬16件: 6, 18, 46, 49, 51, 56, 57, 62, 65, 67, 79, 94, 96, 97, 271, 299 💬
37 Sodium phenylbutyrate 💬1件: Phenylbutyric acid2件: PHENYLBUTYRATE; Sodium Phenylbutyrate--5件: 2, 3, 8, 18, 251 💬
38 Troriluzole 💬1件: Troriluzole1件: Troriluzole14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 18 💬
39 Troriluzole hydrochloride 💬1件: Troriluzole1件: Troriluzole14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		24件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 18 💬
40 Varenicline 💬1件: Varenicline2件: Varenicline; VARENICLINE TARTRATE2件: CHRNA4,
CHRNB2 💬 		5件: Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬4件: 6, 18, 53, 298 💬
41 Varenicline tartrate 💬1件: Varenicline2件: Varenicline; VARENICLINE TARTRATE2件: CHRNA4,
CHRNB2 💬 		5件: Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬4件: 6, 18, 53, 298 💬
42 Vatiquinone 💬1件: Vatiquinone2件: Alpha-tocotrienol quinone; VATIQUINONE--2件: 18, 21 💬